DOI:
10.7727/wimjopen.2013.325
Synopsis:
Early intervention could slow the decline of FEV1 and FEV1/FVC in patients with chronic obstructive disease (COPD) at stages I and II, and thus delay the progression of early COPD and improve their quality of life.